US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 1.405
  • -0.015-1.06%
Close Apr 26 16:00 ET
  • 1.410
  • +0.005+0.36%
Post 19:57 ET
77.18MMarket Cap-534P/E (TTM)

Marinus Pharmaceuticals Key Stats

Marinus Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 5, 2024

Revenue(YoY)

7.19M

+0.39%
EPS(YoY)

-0.74

+2.63%

Buy

Apr 28, 2024

Marinus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 9.587M--
--2024/Q1-- / 9.125M--
Mar 5, 20242023/Q47.190M / 8.139M--
Nov 7, 20232023/Q37.338M / 6.315M--
Aug 10, 20232023/Q26.081M / 5.735M--
May 11, 20232023/Q110.380M / 4.907M--
Mar 7, 20232022/Q47.162M / 9.148M--
Nov 8, 20222022/Q32.340M / 25.761M--
Aug 11, 20222022/Q21.790M / 2.315M--
May 12, 20222022/Q114.186M / 2.277M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 9.587M--
--2024/Q1-- / 9.125M--
Mar 5, 20242023/Q47.190M / 8.139M--
Nov 7, 20232023/Q37.338M / 6.315M--
Aug 10, 20232023/Q26.081M / 5.735M--
May 11, 20232023/Q110.380M / 4.907M--
Mar 7, 20232022/Q47.162M / 9.148M--
Nov 8, 20222022/Q32.340M / 25.761M--
Aug 11, 20222022/Q21.790M / 2.315M--
May 12, 20222022/Q114.186M / 2.277M--

Unlock Free Earnings Estimates

Marinus Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 28, 2024

Buy

  • Buy

    72.73%
  • Hold

    27.27%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg